TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth
Open accessThe DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Abstract
Malignant mesothelioma (MM) is an incurable malignancy that is caused by exposure to asbestos and is accompanied by severe fibrosis. Because MM is usually diagnosed at an advanced stage and clinical identification of early lesions is difficult, its molecular pathogenesis has not been completely elucidated. Nearly 75% of MM cases have inactivating mutations in the NF2 (neurofibromatosis type 2; Merlin) gene or in downstream signaling molecules of the Hippo signaling cascade, which negatively regulates the transcription factor Yes-associated protein (YAP). In this study, we demonstrate a functional interaction between the Hippo and TGF-β pathways in regulating connective tissue growth factor (CTGF). Expression of CTGF in MM cells was induced by the formation of a YAP-TEAD4-Smad3-p300 complex on the CTGF promoter. Knocking down CTGF expression in MM cells prolonged the survival of xenografted mice, and a significant association was seen between CTGF expression and extracellular matrix deposition in MM xenografts and in patient tissue specimens. We further suggest that CTGF may influence the malignancy of mesothelioma because of the different histological expression patterns observed in human MM tissues. These data suggest that CTGF is an important modulator of MM growth and pathology and represents a novel therapeutic target for this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As previously mentioned in this review, TGF-β itself and its family members have been recognized to be involved in cancer development [81], and TGF-β possesses a pro-oncogenic role in MPM connected to immune suppression [82,83].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [83]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907 · cited 1×
“Subsequent studies further revealed that TGF- acts as a tumor suppressor in premalignant cells as well as cells progressing through the early stages of carcinogenesis; furthermore, it exerts prooncogenic effects in metastatic tumors (Roberts and Wakefield, 2003; Massagué, 2008).”
BackgroundTEAD mediates YAP-dependent gene induction and growth control
Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M., et al. (2008) · Genes & Development · doi:10.1101/gad.1664408 · Cited by 2,498 · cited 6×
“In addition to recent studies that indicate that tumor cell–derived CTGF plays an important role in the proliferation of breast cancer cells (Zhao et al., 2008) and growth of pancreatic tumors (Bennewith et al.”
BackgroundMethodInfluentialMassagué, J., Seoane, J., & Wotton, D. (2005) · Genes & Development · doi:10.1101/gad.1350705 · Cited by 2,452
Elucidation of a universal size-control mechanism in Drosophila and mammals
Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., Anders, R. A., Maitra, A., & Pan, D. (2007) · Cell · doi:10.1016/j.cell.2007.07.019 · Cited by 2,370
Growth factors from murine sarcoma virus-transformed cells.
de Larco, J. E., & Todaro, G. J. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.8.4001 · Cited by 1,461
Wu, S., Huang, J., Dong, J., & Pan, D. (2003) · Cell · doi:10.1016/s0092-8674(03)00549-x · Cited by 1,098
Advances in Malignant Mesothelioma
Robinson, B. W. S., & Lake, R. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050152 · Cited by 889
Zhang, N., Bai, H., David, K. K., Dong, J., Zheng, Y., Cai, J., Giovannini, M., Liu, P., Anders, R. A., & Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.06.015 · Cited by 804
Hamaratoglu, F., Willecke, M., Kango-Singh, M., Nolo, R., Hyun, E., Tao, C., Jafar-Nejad, H., & Halder, G. (2006) · Nature Cell Biology · doi:10.1038/ncb1339 · Cited by 767
Cited by
YAP/TAZ at the Roots of Cancer
Zanconato, F., Cordenonsi, M., & Piccolo, S. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.05.005 · Cited by 1,970
“((Bueno et al., 2016) IHC: YAP levels are upregulated in about 70% of mesotheliomas (Fujii et al., 2012; Murakami et al., 2011) YAP knockdown impairs the growth of mesothelioma cell lines Osteosarcoma (OS) None reported IHC: YAP levels are upregulated in about 80% of OS compared to normal bone…”
BackgroundThe emerging roles of YAP and TAZ in cancer
Moroishi, T., Hansen, C. G., & Guan, K.-L. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3876 · Cited by 1,145
Hippo–YAP/TAZ signalling in organ regeneration and regenerative medicine
Moya, I. M., & Halder, G. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0086-y · Cited by 981
Signaling Cross Talk between TGF-β/Smad and Other Signaling Pathways
Luo, K. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022137 · Cited by 639
Developmental pathways in the pathogenesis of lung fibrosis
Chanda, D., Otoupalova, E., Smith, S. R., Volckaert, T., De Langhe, S. P., & Thannickal, V. J. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.08.004 · Cited by 514
The Hippo pathway in the heart: pivotal roles in development, disease, and regeneration
Wang, J., Liu, S., Heallen, T., & Martin, J. F. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0063-3 · Cited by 380
Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation
Morris, L. G. T., Kaufman, A. M., Gong, Y., Ramaswami, D., Walsh, L. A., Turcan, Ş., Eng, S., Kannan, K., Zou, Y., Peng, L., et al. (2013) · Nature Genetics · doi:10.1038/ng.2538 · Cited by 366
ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types
Lehmann, W., Mossmann, D., Kleemann, J., Mock, K., Meisinger, C., Brummer, T., Herr, R., Brabletz, S., Stemmler, M. P., & Brabletz, T. (2016) · Nature Communications · doi:10.1038/ncomms10498 · Cited by 305
Beyer, T. A., Weiss, A., Khomchuk, Y., Huang, K., Ogunjimi, A. A., Varelas, X., & Wrana, J. L. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.11.021 · Cited by 292
Molecular pathogenesis of malignant mesothelioma
Sekido, Y. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt166 · Cited by 279
Self-citationYAP/TAZ Signaling as a Molecular Link between Fibrosis and Cancer
Noguchi, S., Saito, A., & Nagase, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113674 · Cited by 277
Many ways to resistance: How melanoma cells evade targeted therapies
Kozar, I., Margue, C., Rothengatter, S., Haan, C., & Kreis, S. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.02.002 · Cited by 270
Regulation of TEAD Transcription Factors in Cancer Biology
Huh, H., Kim, D., Jeong, H.-S., & Park, H. (2019) · Cells · doi:10.3390/cells8060600 · Cited by 259
Targeting TGF-β Signaling for Therapeutic Gain
Akhurst, R. J. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022301 · Cited by 241
Dou, C., Liu, Z., Tu, K., Zhang, H., Chen, C., Yaqoob, U., Wang, Y., Wen, J., van Deursen, J., Sicard, D., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.02.015 · Cited by 240
YAP Is Essential for Treg-Mediated Suppression of Antitumor Immunity
Ni, X., Tao, J., Barbi, J., Chen, Q., Park, B. V., Li, Z., Zhang, N., Lebid, A., Ramaswamy, A., Wei, P., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1124 · Cited by 231
Hiemer, S. E., Szymaniak, A. D., & Varelas, X. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.529115 · Cited by 227
“Therefore, as in malignant mesotheliomas (31), the synergistic regulation of the CTGF promoter likely promotes aggressive breast cancer phenotypes.”
BackgroundInfluentialKaneda, A., Seike, T., Danjo, T., Nakajima, T., Otsubo, N., Yamaguchi, D., Tsuji, Y., Hamaguchi, K., Yasunaga, M., Nishiya, Y., et al. (2020) · American Journal of Cancer Research · Cited by 208
Self-citationThe Hippo pathway in normal development and cancer
Maugeri-Saccà, M., & De Maria, R. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.12.011 · Cited by 167
YAP and TAZ Are Not Identical Twins
Reggiani, F., Gobbi, G., Ciarrocchi, A., & Sancisi, V. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.08.012 · Cited by 167
Signal integration in TGF-β, WNT, and Hippo pathways
Attisano, L., & Wrana, J. L. (2013) · F1000Prime Reports · doi:10.12703/p5-17 · Cited by 166
YAP/TAZ Activation as a Target for Treating Metastatic Cancer
Warren, J., Xiao, Y., & Lamar, J. (2018) · Cancers · doi:10.3390/cancers10040115 · Cited by 164
Qin, Z., Xia, W., Fisher, G. J., Voorhees, J. J., & Quan, T. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0232-3 · Cited by 158
TGF-β Targets the Hippo Pathway Scaffold RASSF1A to Facilitate YAP/SMAD2 Nuclear Translocation
Pefani, D., Paňková, D., Abraham, A., Grawenda, A. M., Vlahov, N., Scrace, S., & Neill, E. O. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.05.012 · Cited by 149
Nokin, M.-J., Durieux, F., Peixoto, P., Chiavarina, B., Peulen, O., Blomme, A., Turtoi, A., Costanza, B., Smargiasso, N., Baiwir, D., et al. (2016) · eLife · doi:10.7554/elife.19375 · Cited by 137
Collagen abundance controls melanoma phenotypes through lineage-specific microenvironment sensing
Miskolczi, Z., Smith, M. P., Rowling, E. J., Ferguson, J., Barriuso, J., & Wellbrock, C. (2018) · Oncogene · doi:10.1038/s41388-018-0209-0 · Cited by 126
Huang, J., Zhuang, C., Chen, J., Chen, X., Li, X., Zhang, T., Wang, B., Feng, Q., Zheng, X., Gong, M., et al. (2022) · Advanced Materials · doi:10.1002/adma.202201516 · Cited by 119
Targeting CTGF in Cancer: An Emerging Therapeutic Opportunity
Shen, Y., Zhou, Y., Chen, H., Luan, X., & Zhang, W. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.12.001 · Cited by 118
Cross-talk between Wnt/β-catenin and Hippo signaling pathways: a brief review
Kim, M., & Jho, E. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.10.177 · Cited by 115
Zyxin-Siah2–Lats2 axis mediates cooperation between Hippo and TGF-β signalling pathways
Ma, B., Cheng, H., Gao, R., Mu, C., Chen, L., Wu, S., Chen, Q., & Zhu, Y. (2016) · Nature Communications · doi:10.1038/ncomms11123 · Cited by 111
YAP regulates cell proliferation, migration, and steroidogenesis in adult granulosa cell tumors
Fu, D., Lv, X., Hua, G., He, C., Dong, J., Lele, S. M., Li, D. W.-C., Zhai, Q., Davis, J. S., & Wang, C. (2014) · Endocrine-Related Cancer · doi:10.1530/erc-13-0339 · Cited by 106
Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo
Greening, D. W., Ji, H. L., Chen, M., Robinson, B. W. S., Dick, I. M., Creaney, J., & Simpson, R. J. (2016) · Scientific Reports · doi:10.1038/srep32643 · Cited by 105
Malignant mesothelioma as an oxidative stress-induced cancer: An update
Chew, S. H., & Toyokuni, S. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.05.002 · Cited by 102
YAP and TAZ Take Center Stage in Cancer
Zhang, K., Qi, H.-X., Hu, Z., Chang, Y., Shi, Z., Han, X., Han, Y., Zhang, R., Zhang, Z., Chen, T., et al. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b01014 · Cited by 100
Gastric Tumor Microenvironment
Rojas, A., Araya, P., González, I., & Morales, E. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-36214-0_2 · Cited by 99
Toyokuni, S. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.10.401 · Cited by 96
Mechanical control of nuclear import by Importin-7 is regulated by its dominant cargo YAP
García-García, M., Sánchez-Perales, S., Jarabo, P., Calvo, E., Huyton, T., Fu, L., Ng, S. C., Sotodosos-Alonso, L., Vázquez, J., Casas‐Tintó, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28693-y · Cited by 94
Wang, Y., Tu, K., Liu, D., Guo, L., Chen, Y., Li, Q., Maiers, J. L., Liu, Z., Shah, V. H., Dou, C., et al. (2019) · Hepatology · doi:10.1002/hep.30668 · Cited by 93
Hippo and TGF-β interplay in the lung field
Saito, A., & Nagase, T. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00238.2015 · Cited by 91
Emerging role of Hippo pathway in gastric and other gastrointestinal cancers
Kang, W., Cheng, A. S. L., Yu, J., & To, K. F. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i3.1279 · Cited by 91
The role of Hippo signal pathway in breast cancer metastasis
Wei, C., Wang, Y., & Li, X. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s157058 · Cited by 89
Caveolin1 and YAP drive mechanically induced mesothelial to mesenchymal transition and fibrosis
Strippoli, R., Sandoval, P., Moreno-Vicente, R., Rossi, L., Battistelli, C., Terri, M., Pascual‐Antón, L., Loureiro, M., Matteini, F., Calvo, E., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02822-1 · Cited by 87
Deregulation of Hippo–TAZ pathway during renal injury confers a fibrotic maladaptive phenotype
Anorga, S., Overstreet, J. M., Falke, L. L., Tang, J., Goldschmeding, R. G., Higgins, P. J., & Samarakoon, R. (2018) · The FASEB Journal · doi:10.1096/fj.201700722r · Cited by 85
Tanaka, I., Osada, H., Fujii, M., Fukatsu, A., Hida, T., Horio, Y., Kondo, Y., Sato, A., Hasegawa, Y., Tsujimura, T., et al. (2013) · Oncogene · doi:10.1038/onc.2013.528 · Cited by 85
Self-citationDeregulation of Negative Controls on TGF-β1 Signaling in Tumor Progression
Tang, J., Gifford, C., Samarakoon, R., & Higgins, P. (2018) · Cancers · doi:10.3390/cancers10060159 · Cited by 77
Liu, H., Sun, M., Wu, N., Liu, B., Liu, Q., & Fan, X. (2023) · Immunity Inflammation and Disease · doi:10.1002/iid3.1060 · Cited by 76
Narimatsu, M., Samavarchi‐Tehrani, P., Varelas, X., & Wrana, J. L. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.02.019 · Cited by 74
HIF-hypoxia signaling in skeletal muscle physiology and fibrosis
Valle-Tenney, R., Rebolledo, D. L., Acuña, M. J., & Brandan, E. (2020) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-020-00553-8 · Cited by 72
Rehrauer, H., Wu, L., Blum, W., Pecze, L., Henzi, T., Serre-Beinier, V., Aquino, C., Vrugt, B., de Perrot, M., Schwaller, B., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0153-z · Cited by 69
The Immune Microenvironment in Mesothelioma: Mechanisms of Resistance to Immunotherapy
Chu, G. J., van Zandwijk, N., & Rasko, J. E. J. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01366 · Cited by 70
PTPN14 phosphatase and YAP promote TGFβ signalling in rheumatoid synoviocytes
Bottini, A., Wu, D. J., Ai, R., Roux, M. L., Bartók, B., Bombardieri, M., Doody, K. M., Zhang, V., Sacchetti, C., Zoccheddu, M., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-213799 · Cited by 70
Nallet-Staub, F., Yin, X., Gilbert, C., Marsaud, V., Mimoun, S. B., Javelaud, D., Leof, E. B., & Mauviel, A. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.01.011 · Cited by 68
Bertero, T., Cottrill, K. A., Annis, S., Bhat, B., Gochuico, B. R., Osorio, J. C., Rosas, I., Haley, K. J., Corey, K. E., Chung, R. T., et al. (2015) · Scientific Reports · doi:10.1038/srep18277 · Cited by 68
The role of key genes and pathways involved in the tumorigenesis of Malignant Mesothelioma
de Assis, L. V. M., Locatelli, J., & Isoldi, M. C. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.01.008 · Cited by 66
YAP1 is essential for osteoclastogenesis through a TEADs-dependent mechanism
Zhao, L., Guan, H., Song, C., Wang, Y., Liu, C. Y., Cai, C., Zhu, H., Liu, H., Zhao, L., & Xiao, J. (2018) · Bone · doi:10.1016/j.bone.2018.01.035 · Cited by 66
Dysregulation of the Hippo pathway signaling in aging and cancer
Yeung, Y. T., Guerrero‐Castilla, A., Cano, M., Muñoz, M. F., Ayala, A., & Argüelles, S. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.03.018 · Cited by 65
Urso, L., Calabrese, F., Favaretto, A. G., Conte, P., & Pasello, G. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.08.019 · Cited by 64
Targeting YAP in malignant pleural mesothelioma
Zhang, W., Dai, Y., Hsu, P., Wang, H., Cheng, L., Yang, Y., Wang, Y., Xu, Z., Liu, S., Chan, G., et al. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13182 · Cited by 64
Regulation of Myocardial Cell Growth and Death by the Hippo Pathway
Ikeda, S., & Sadoshima, J. (2016) · Circulation Journal · doi:10.1253/circj.cj-16-0476 · Cited by 63
Crosstalk between YAP and TGFβ regulates SERPINE1 expression in mesenchymal lung cancer cells
Kong, H., Kwon, E., Kwon, O., Lee, H., Choi, J., Kim, Y., Kim, W., & Cha, H. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.5153 · Cited by 62
Tumor Immune Microenvironment and Genetic Alterations in Mesothelioma
Hiltbrunner, S., Mannarino, L., Kirschner, M. B., Opitz, I., Rigutto, A., Laure, A., Lia, M., Nozza, P., Maconi, A., Marchini, S., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.660039 · Cited by 62
Yap control of tissue growth relies on cell density and F-actin in zebrafish fin regeneration
Mateus, R., Lourenço, R., Fang, Y., Brito, G., Farinho, A., Valério, F., & Jacinto, A. (2015) · Development · doi:10.1242/dev.119701 · Cited by 60
Src‐mediated crosstalk between FXR and YAP protects against renal fibrosis
Kim, D., Choi, H., Park, J. S., Kim, C. S., Bae, E. H., Kwon, S., & Kim, S. W. (2019) · The FASEB Journal · doi:10.1096/fj.201900325r · Cited by 59
YAP in pancreatic cancer: oncogenic role and therapeutic strategy
Mao, W., Mai, J., Peng, H., Wan, J., & Sun, T. (2020) · Theranostics · doi:10.7150/thno.53438 · Cited by 60
TFCP2 Is Required for YAP-Dependent Transcription to Stimulate Liver Malignancy
Zhang, X., Sun, F., Qiao, Y., Zheng, W., Liu, Y., Chen, Y., Wu, Q., Liu, X., Zhu, G., Chen, Y., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.017 · Cited by 58
Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma
Sekido, Y. (2018) · Cancers · doi:10.3390/cancers10040090 · Cited by 58
Self-citationThe Antifibrotic Activity of Prostacyclin Receptor Agonism Is Mediated through Inhibition of YAP/TAZ
Zmajkovicova, K., Menyhart, K., Bauer, Y., Studer, R. O., Renault, B., Schnoebelen, M., Bolinger, M., Nayler, O., & Gatfield, J. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0142oc · Cited by 59
Li, H., Li, Q.-Y., Jin, M.-J., Lu, C.-F., Mu, Z.-Y., Xu, W., Song, J., Zhang, Y., & Zhang, S. (2021) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-021-03604-8 · Cited by 58
Bian, S., Yang, Y. S., Liang, W., Zhang, K., Chen, L., & Zhang, Z.-T. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14466 · Cited by 56
It Takes Two to Tango: Endothelial TGFβ/BMP Signaling Crosstalk with Mechanobiology
Hiepen, C., Mendez, P., & Knaus, P. I. (2020) · Cells · doi:10.3390/cells9091965 · Cited by 55
Fujii, M., Nakanishi, H., Toyoda, T., Tanaka, I., Kondo, Y., Osada, H., & Sekido, Y. (2012) · Cell Cycle · doi:10.4161/cc.21397 · Cited by 53
Self-citationLiu, Z., Hayashi, H., Matsumura, K., Ogata, Y., Sato, H., Shiraishi, Y., Uemura, N., Miyata, T., Higashi, T., Nakagawa, S., et al. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-02106-9 · Cited by 53
Almontashiri, N. A. M., Antoine, D., Zhou, X., Vilmundarson, R. O., Zhang, S. X., Hao, K. N., Chen, H., & Stewart, A. F. R. (2015) · Circulation · doi:10.1161/circulationaha.114.015023 · Cited by 52
Concurrent YAP/TAZ and SMAD signaling mediate vocal fold fibrosis
Nakamura, R., Hiwatashi, N., Bing, R., Doyle, C. P., & Branski, R. C. (2021) · Scientific Reports · doi:10.1038/s41598-021-92871-z · Cited by 51
Progress with YAP/TAZ-TEAD inhibitors: a patent review (2018-present)
Zagiel, B., Melnyk, P., & Cotelle, P. (2022) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2022.2096436 · Cited by 50
Ando, T., Charindra, D., Shrestha, M., Umehara, H., Ogawa, I., Miyauchi, M., & Takata, T. (2017) · Oncogene · doi:10.1038/onc.2017.321 · Cited by 49
YAP Regulates the Expression of Hoxa1 and Hoxc13 in Mouse and Human Oral and Skin Epithelial Tissues
Liu, M., Zhao, S., Lin, Q., & Wang, X. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00765-14 · Cited by 48
Metabolic Rewiring and Redox Alterations in Malignant Pleural Mesothelioma
Urso, L., Cavallari, I., Sharova, E., Ciccarese, F., Pasello, G., & Ciminale, V. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0661-9 · Cited by 47
“Immunohistochemical (IHC) analysis of MPM tissues revealed strong nuclear accumulation of phospho-SMAD2, suggesting constitutive activation of TGF-β signalling in this cancer.(44) Using an immunocompetent syngeneic mouse model, Suzuki et al.”
BackgroundEmerging role of Hippo signalling pathway in bladder cancer
Xia, J., Zeng, M., Zhu, H., Chen, X., Weng, Z., & Li, S. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13293 · Cited by 47
YAP and TAZ are distinct effectors of corneal myofibroblast transformation
Muppala, S., Raghunathan, V. K., Jalilian, I., Thomasy, S. M., & Murphy, C. J. (2018) · Experimental Eye Research · doi:10.1016/j.exer.2018.12.009 · Cited by 47
LINC00968 can inhibit the progression of lung adenocarcinoma through the miR-21-5p/SMAD7 signal axis
Zhu, Y., Bo, H., Chen, Z., Li, J., He, D., Xiao, M., Xiang, L., Jin, L., Zhou, J., Gong, L., et al. (2020) · Aging · doi:10.18632/aging.104011 · Cited by 47
Ramundo, V., Zanirato, G., & Aldieri, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212216 · Cited by 46
Ma, L., Jiang, H., Xu, X., Zhang, C., Niu, Y., Wang, Z., Tao, Y., Li, Y., Cai, F., Zhang, X., et al. (2019) · Aging · doi:10.18632/aging.102420 · Cited by 46
Functional Genomics of the 9p21.3 Locus for Atherosclerosis: Clarity or Confusion?
Chen, H.-H., Almontashiri, N. A. M., Antoine, D., & Stewart, A. F. R. (2014) · Current Cardiology Reports · doi:10.1007/s11886-014-0502-7 · Cited by 45
Zhang, C., Yang, D., Wang, T., Nie, X., Chen, G., Wang, L., You, Y., & Wang, Q. (2022) · Biomaterials Science · doi:10.1039/d2bm01493a · Cited by 45
Transforming growth factor-β signaling: from tumor microenvironment to anticancer therapy
Chan, M. K., Chan, E. L.-Y., Ji, Z. Z., Chan, A. S. W., Li, C., Leung, K. T., To, K., & Tang, P. M. (2023) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2023.00137 · Cited by 45
Ohara, Y., Chew, S. H., Misawa, N., Wang, S., Somiya, D., Nakamura, K., Kajiyama, H., Kikkawa, F., Tsuyuki, Y., Jiang, L., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24892 · Cited by 44
Self-citationChang, H., Fang, Y., Liu, P.-P., Cheng, J., Yang, X., & Leung, P. C. K. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.07.007 · Cited by 43
GPCR-induced YAP activation sensitizes fibroblasts to profibrotic activity of TGFβ1
Zmajkovicova, K., Bauer, Y., Menyhart, K., Schnoebelen, M., Freti, D., Boucher, M., Renault, B., Studer, R. O., Birker, M., Klenk, A., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228195 · Cited by 44
Mesothelioma Malignancy and the Microenvironment: Molecular Mechanisms
Cersosimo, F., Barbarino, M., Lonardi, S., Vermi, W., Giordano, A., Bellan, C., & Giurisato, E. (2021) · Cancers · doi:10.3390/cancers13225664 · Cited by 41
“express the CTGF as modulator of ECM-related proteins and supporter of cancer invasiveness [62].”
BackgroundInfluentialZhuang, C., Liu, Y., Fu, S., Yuan, C., Luo, J., Huang, X., Yang, W., Xie, W., & Zhuang, C. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.616768 · Cited by 41
NF2 alteration in mesothelioma
Sekido, Y., & Sato, T. (2023) · Frontiers in Toxicology · doi:10.3389/ftox.2023.1161995 · Cited by 40
Self-citationA dual role of YAP in driving TGFβ-mediated endothelial-to-mesenchymal transition
Savorani, C., Malinverno, M., Seccia, R., Maderna, C., Giannotta, M., Terreran, L., Mastrapasqua, E., Campaner, S., Dejana, E., & Giampietro, C. (2021) · Journal of Cell Science · doi:10.1242/jcs.251371 · Cited by 40
Pan, Z., Tian, Y., Zhang, B., Zhang, X., Shi, H., Liang, Z., Wu, P., Li, R., You, B., Yang, L., et al. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4101 · Cited by 40
Fiorilla, I., Martinotti, S., Todesco, A. M., Bonsignore, G., Cavaletto, M., Patrone, M., Ranzato, E., & Audrito, V. (2023) · Cells · doi:10.3390/cells12162048 · Cited by 39
“As previously mentioned in this review, TGF-β itself and its family members have been recognized to be involved in cancer development [81], and TGF-β possesses a pro-oncogenic role in MPM connected to immune suppression [82,83].”
BackgroundMeerang, M., Bérard, K., Friess, M., Bitanihirwe, B. K. Y., Soltermann, A., Vrugt, B., Felley‐Bosco, E., Bueno, R., Richards, W. G., Seifert, B., et al. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.06.005 · Cited by 39
Heterotypic 3D pancreatic cancer model with tunable proportion of fibrotic elements
Tanaka, H. Y., Kurihara, T., Nakazawa, T., Matsusaki, M., Masamune, A., & Kano, M. R. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120077 · Cited by 39
An Updated Understanding of the Role of YAP in Driving Oncogenic Responses
Morciano, G., Vezzani, B., Missiroli, S., Boncompagni, C., Pinton, P., & Giorgi, C. (2021) · Cancers · doi:10.3390/cancers13123100 · Cited by 39
The role of extracellular biophysical cues in modulating the Hippo-YAP pathway
Mo, J. (2017) · BMB Reports · doi:10.5483/bmbrep.2017.50.2.199 · Cited by 39
Ohara, Y., Enomoto, A., Tsuyuki, Y., Sato, K., Iida, T., Kobayashi, H., Mizutani, Y., Miyai, Y., Hara, A., Mii, S., et al. (2020) · Oncology Reports · doi:10.3892/or.2020.7669 · Cited by 38
Metadata
- Authors
- Fujii, M., Toyoda, T., Nakanishi, H., Yatabe, Y., Sato, A., Matsudaira, Y., Ito, H., Murakami, H., Kondo, Y., Kondo, E., Hida, T., Tsujimura, T., Osada, H., & Sekido, Y.
- Affiliations
- Aichi Cancer Center (JP)
- National Institute of Health Sciences (JP)
- Hyogo Medical University (JP)
- Corresponding author
- Fujii, Makiko
- Sekido, Yoshitaka
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2012-02-13
- Volume
- 209
- Issue
- 3
- Pages
- 479-494
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC3302232
- OpenAlex
- W2100842035
- Cited by
- 224
- References
- 47
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 18 · 2023: 10 · 2022: 19 · 2021: 23 · 2020: 21 · 2019: 19 · 2018: 30 · 2017: 14 · 2016: 16 · 2015: 16 · 2014: 12 · 2013: 9 · 2012: 4
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- Takeda Science Foundation (H18-1-3-3-1)
- Ministry of Education, Culture, Sports, Science and Technology (H18-1-3-3-1)
- Kobayashi Foundation for Cancer Research
- Aichi Cancer Research Foundation
- Vlaamse regering
- Japan Society for the Promotion of Science (23592788, H18-1-3-3-1, 22590375, 22700935, 22300338, 21590457, 20590420, 23590438)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- malignant mesothelioma, TGF-beta signaling, Hippo signaling pathway, connective tissue growth factor, YAP, neurofibromatosis type 2, Merlin, Smad3, TEAD4, P300, extracellular matrix deposition, tumor growth, asbestos, therapeutic target
- MeSH terms
- Animals, Base Sequence, DNA, Neoplasm, Extracellular Matrix, Female, Humans, Mesothelioma, Mice, Nude, Molecular Sequence Data, Nuclear Proteins, Promoter Regions, Genetic, Transcription Factors, Signal Transduction, Transcriptional Activation, Gene Expression, Transforming Growth Factor beta, Genes, Neurofibromatosis 2, Cell Cycle Proteins, Cell Line, Tumor, Cell Proliferation, Mice, Smad Proteins, Connective Tissue Growth Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.